Arkolith/Insider Trading/THRX/Form 4

Gordon Carl L

Director, 10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Oct 14, 2021
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 12, 2021Buy(P)63K$16.00$1.0M499K
Oct 12, 2021Buy(P)563K$16.00$9.0M16.3M
Oct 12, 2021Conversion(C)437K——437K
Oct 12, 2021Conversion(C)15.8M——15.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 12, 2021Conversion(C)14.9M——0
Oct 12, 2021Conversion(C)437K——0
Oct 12, 2021Conversion(C)873K——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-040256) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML